COSTA, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.989
AS - Asia 3.440
EU - Europa 3.079
SA - Sud America 668
AF - Africa 102
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.293
Nazione #
US - Stati Uniti d'America 3.881
SG - Singapore 1.545
BR - Brasile 505
IE - Irlanda 504
HK - Hong Kong 493
CN - Cina 489
IT - Italia 445
RU - Federazione Russa 418
VN - Vietnam 382
FR - Francia 370
UA - Ucraina 314
DE - Germania 245
SE - Svezia 227
FI - Finlandia 176
GB - Regno Unito 119
KR - Corea 119
IN - India 80
AR - Argentina 61
NL - Olanda 56
CA - Canada 48
BD - Bangladesh 41
TR - Turchia 39
IQ - Iraq 36
RO - Romania 34
MX - Messico 33
JP - Giappone 30
PK - Pakistan 30
ID - Indonesia 28
PL - Polonia 28
ZA - Sudafrica 27
AT - Austria 26
BE - Belgio 22
SA - Arabia Saudita 20
VE - Venezuela 19
CL - Cile 18
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
CO - Colombia 16
LT - Lituania 16
MA - Marocco 16
CH - Svizzera 15
EC - Ecuador 15
DZ - Algeria 12
ES - Italia 12
PY - Paraguay 12
PH - Filippine 11
EG - Egitto 10
IL - Israele 9
KE - Kenya 9
LB - Libano 9
MY - Malesia 9
TN - Tunisia 9
BO - Bolivia 8
UY - Uruguay 8
AU - Australia 7
GR - Grecia 7
AE - Emirati Arabi Uniti 6
ET - Etiopia 6
KZ - Kazakistan 6
PE - Perù 6
PS - Palestinian Territory 6
AL - Albania 5
AZ - Azerbaigian 5
EU - Europa 5
JO - Giordania 4
BB - Barbados 3
CR - Costa Rica 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
BG - Bulgaria 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DM - Dominica 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AD - Andorra 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HR - Croazia 1
Totale 11.269
Città #
Singapore 1.109
Chandler 566
Dublin 499
Hong Kong 490
San Jose 337
Ashburn 260
Boardman 203
San Mateo 203
Jacksonville 171
Santa Clara 163
Moscow 148
Beijing 146
Altamura 137
Perugia 134
Lauterbourg 129
Seoul 119
Medford 111
Dong Ket 108
Princeton 108
Lawrence 101
Munich 91
Wilmington 86
Ann Arbor 82
Ho Chi Minh City 80
Andover 74
Los Angeles 67
Hanoi 62
The Dalles 59
Turku 58
Des Moines 52
Helsinki 48
São Paulo 48
Redmond 43
Piscataway 40
Amsterdam 34
Frankfurt am Main 34
New York 34
London 29
Orem 25
Rio de Janeiro 22
Tokyo 22
San Paolo di Civitate 21
Warsaw 21
Brussels 20
Dallas 20
Brooklyn 19
Bucharest 19
Saint Petersburg 19
Houston 18
Nuremberg 18
Woodbridge 18
Atlanta 17
Chennai 17
Council Bluffs 17
Montreal 17
Norwalk 17
Chicago 16
Denver 16
Johannesburg 16
Stockholm 16
Baghdad 15
Haiphong 15
Poplar 14
Brasília 13
Falkenstein 13
Boston 12
Florence 11
Milan 11
Tashkent 11
Campinas 10
Columbus 10
Curitiba 10
Da Nang 10
Izmir 10
New Delhi 10
Riyadh 10
Tianjin 10
Falls Church 9
Istanbul 9
Jakarta 9
Mexico City 9
Phoenix 9
Redwood City 9
San Francisco 9
Asunción 8
Belo Horizonte 8
Boydton 8
Medellín 8
Naples 8
Toronto 8
Caracas 7
Goiânia 7
Guarulhos 7
Nairobi 7
Olomouc 7
Rome 7
Santiago 7
Vienna 7
Zhengzhou 7
Ankara 6
Totale 7.049
Nome #
Alpha-Synuclein Produces Early Behavioral Alterations Via Striatal Cholinergic Synaptic Dysfunction by Interacting with GluN2D N-Methyl-D-Aspartate Receptor Subunit 216
A critical role of NO/cGMP/PKG dependent pathway in hippocampalpost-ischemic LTP: modulation by zonisamide. 148
Microglial activation and the nitric oxide/cGMP/PKG pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis 139
Decreased NR2B Subunit Synaptic Levels Cause Impaired Long-Term Potentiation But Not Long-Term Depression 134
Hippocampal epileptogenesis in autoimmune encephalitis 131
Brain arteriovenous malformations and seizures: an Italian study. 128
c-Jun N-terminal Kinase regulates soluble Abeta oligomers and cognitive impairment in an AD mouse model. 123
Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease 122
Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. 121
A2A Adenosine Receptor Antagonism Enhances Synaptic and Motor Effects of Cocaine via CB1 Cannabinoid Receptor Activation. 120
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 120
Effects of central and peripheral inflammation on hippocampal synaptic plasticity 119
A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy. 119
Alectinib's activity against CNS metastases from ALK-positive non-small cell lung cancer: a single institution case series 118
A2A adenosine receptor antagonists protect the striatum against rotenone-induced neurotoxicity 117
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 116
Low doses of Perampanel protect striatal and hippocampal neurons against in vitro ischemia by reversing the ischemia-induced alteration of AMPA receptor subunit composition 116
Occipital arteriovenous malformations andmigraine. 113
Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis 113
Plasticity and repair in the post-ischemic brain 113
Interleukin-17 affects synaptic plasticity and cognition in an experimental model of multiple sclerosis 113
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. 112
Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications 112
Levetiracetam-associated hyponatremia. 111
Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system 111
Electrophysiological actions of zonisamide on striatal neurons: Selective neuroprotection against complex I mitochondrial dysfunction. 110
An Italian multicentre study of perampanel in progressive myoclonus epilepsies 110
Management of epilepsy in brain tumors 110
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine. 108
Critical role of calcitonin gene-related peptide receptors in cortical spreading depression. 107
A 1H magnetic resonance spectroscopy study in patients with obstructive sleep apnea. 106
Developmental impaired Akt signaling in the Shank1 and Shank3 double knock-out mice 106
Amyloid-β: a potential link between epilepsy and cognitive decline 105
Ischemic-LTP in striatal spiny neurons of both direct and indirect pathway requires the activation of D1-like receptors and NO/soluble guanylate cyclase/cGMP transmission. 101
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 101
Differential effect of FHM2 mutation on synaptic plasticity in distinct hippocampal regions 101
Cannabidiol: metabolism and clinical efficacy in epileptic patients 99
Effect of psychotropic drugs on seizure threshold 99
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 99
Region- and age-dependent reductions of hippocampal long-term potentiation and NMDA to AMPA ratio in a genetic model of Alzheimer's disease. 99
Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice. 98
Rapid effect of levetiracetam in a case of juvenile myoclonic epilepsy 96
Lacosamide protects striatal and hippocampal neurons from in vitro ischemia without altering physiological synaptic plasticity 96
Synaptic vesicle protein 2A tumoral expression predicts levetiracetam adverse events 96
Sleep disorders and late-onset epilepsy of unknown origin: Understanding new trajectories to brain amyloidopathy 96
Liverpool Adverse Events Profile: Italian validation and predictive value for dropout from antiepileptic treatment in people with epilepsy 95
Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment. 94
Neural 17beta-estradiol facilitates long-term potentiation in the hippocampal CA1 region 94
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: Role of Na(+)/K(+) ATPase. 91
Cortical spreading depression as a target for anti-migraine agents. 91
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 91
Effect of Brivaracetam on Efficacy and Tolerability in Patients With Brain Tumor-Related Epilepsy: A Retrospective Multicenter Study 90
Evaluating bexicaserin for the treatment of developmental epileptic encephalopathies 89
Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis (Scientific Reports (2016) 6 (20926) DOI: 10.1038/srep20926) 89
O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events? 88
Obsessive-compulsive disorder and migraine with medication-overuse headache. 88
Late-Onset Epilepsy With Unknown Etiology: A Pilot Study on Neuropsychological Profile, Cerebrospinal Fluid Biomarkers, and Quantitative EEG Characteristics 87
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. 86
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 86
The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease. 85
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 84
Late onset epilepsy and Alzheimer's disease: exploring the dual pathogenic role of amyloid-β 83
Incidence and Antiseizure Medications of Post-stroke Epilepsy in Umbria: A Population-Based Study Using Healthcare Administrative Databases 83
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 83
Hyperhomocysteinemia and retinal vascular changes in patients with epilepsy. 82
Chronic cocaine prevents depotentiation at corticostriatal synapses. 82
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 82
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 81
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia. 80
Neuropsychiatric adverse events of antiepileptic drugs in brain tumour-related epilepsy: an Italian multicentre prospective observational study 80
Two-year longitudinal monitoring of amnestic mild cognitive impairment patients with prodromal Alzheimer's disease using topographical biomarkers derived from functional magnetic resonance imaging and electroencephalographic activity 80
An unbalanced synaptic transmission: Cause or consequence of the amyloid oligomers neurotoxicity? 80
Na+/Ca2+ exchanger maintains ionic homeostasis in the peri-infarct area. 78
A loss-of-function HCN4 mutation associated with familial benign myoclonic epilepsy in infancy causes increased neuronal excitability 78
Striatal spreading depolarization: Possible implication in levodopa-induced dyskinetic-like behavior 78
Degradation of endocannabinoids in chronic migraine and medication overuse headache. 77
MBOAT7 encephalopathy: Characterizing the neurology and epileptology 76
Levetiracetam in newly diagnosed late-onset post-stroke seizures: a prospective observational study. 76
Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. 76
Epm2aR240X knock-in mice present earlier cognitive decline and more epileptic activity than Epm2a-/- mice 75
Environmental enrichment restores CA1 hippocampal LTP and reduces severity of seizures in epileptic mice. 75
Clinical features and outcome of 6 new patients carrying de novoKCNB1gene mutations 75
Migraine and epilepsy: what value today? 75
Cognitive Decline Risk Stratification in People with Late-Onset Epilepsy of Unknown Etiology: An Electroencephalographic Connectivity and Graph Theory Pilot Study 74
Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3 74
Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events? 73
Upfront pembrolizumab as an effective treatment start in patients with PD-L1 ≥ 50% non-oncogene addicted non-small cell lung cancer and asymptomatic brain metastases: an exploratory analysis 73
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences 72
Neuroprotection as a potential therapeutic perspective in neurodegenerative diseases: Focus on antiepileptic drugs 72
Distinct roles for spinophilin and neurabin in dopamine-mediated plasticity. 71
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation. 71
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies. 70
IRF2BPL: A new genotype for progressive myoclonus epilepsies 69
Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia. 69
Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: a prospective observational study. 68
CalDAG-GEFI mediates striatal cholinergic modulation of dendritic excitability, synaptic plasticity and psychomotor behaviors 68
Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome. 67
Locally Synthetized 17-β-Estradiol Reverses Amyloid-β-42-Induced Hippocampal Long-Term Potentiation Deficits 66
Late-onset n-acetylglutamate synthase deficiency: Report of a paradigmatic adult case presenting with headaches and review of the literature 66
Dopaminergic and Behavioral Deficits Caused by Inactivation of the Familial Parkinsonism-Linked Gene DJ-1 65
Totale 9.499
Categoria #
all - tutte 50.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 0 0 0 0 0 0 0 25 59 119
2021/2022901 15 168 30 42 33 13 13 262 19 54 124 128
2022/20231.831 118 377 33 150 165 195 0 67 656 8 45 17
2023/2024803 43 75 34 10 3 3 177 11 117 26 152 152
2024/20251.921 25 162 91 122 220 118 92 154 328 121 324 164
2025/20264.514 296 330 327 649 694 392 728 255 476 367 0 0
Totale 11.573